Question 7068 — overseas

Summary

Mr. Moerani Frébault draws the attention of the Minister of Labor, Health, Solidarity and Families to the worrying situation of health policy in French Polynesia and more particularly to the crucial question of financing expensive molecules, particularly in the treatment of cancers and radiation-induced diseases. Like all overseas territories, French Polynesia is facing challenges specific in terms of public health: geographical fragmentation, isolation, dispersion of infrastructures and health indicators generally less favorable, or even deteriorating, compared to mainland France. Faced with this reality, the State's commitment to strengthening health policies in our territory is essential. Since 2021, the State has redirected its support towards improving the provision of care, the training of health professionals and the development of local research. These objectives are relevant and necessary, but they cannot obscure an urgent and structural need: that of supporting the coverage of the most expensive treatments, which weigh heavily on the Social Security Fund. As an illustration, cancer treatment in French Polynesia represents approximately 3 billion F CFP per year (or approximately 25 million euros), for nearly 800 new patients each year and more than 7,000 patients monitored. Nearly 30 to 40% of this expense is linked to the purchase of expensive molecules. Added to this is the cost of emergency medical evacuations, also borne by the CPS. These costs have now become unsustainable for the local social protection system. Without reinforced state support, continuity and equal access to The most innovative and necessary treatments risk being compromised. This could lead, in the short term, to a deterioration in the quality of care, an increase in evacuations to France and a widening of inequalities between Polynesian, overseas and French patients. The MP would like to point out that the right to access to care for all is guaranteed by the public health code, in particular its article L. 1110-5, which fully applies to overseas territories. It is therefore imperative to translate the principles of national solidarity and territorial equality into concrete actions. In this context, he regrets that the new “State-Country health” convention, although announced by the Minister of Health as having to be finalized in 2025, has still not been initiated. The renewal, for the second time, of the current agreement for one year additional, without a clear perspective, arouses great concern, both among elected officials and health professionals. Also, the MP would like to know precisely the progress of the discussions relating to this new “State-Country health” convention: Will this new framework take into account the financial reality of the CPS? Will it explicitly include support for financing expensive molecules and medical evacuations? And when can we expect to see this agreement come to fruition? He thanks him in advance for the insights that the MP will be able to provide on this situation, which calls for responses commensurate with the human, social and health challenges in French Polynesia.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.